Therapeutic targeting of CHSY1 improves hyperplastic arterial remodeling in vivo
Sep. 4, 2024
Researchers from the National University of Singapore and affiliated organizations presented data from a study that investigated the potential of targeting chondroitin sulfate (CS) synthesis as a therapeutic strategy for ameliorating hyperplastic arterial remodeling.